Yahoo
Jakarta - Delayed Quote IDR

PT Itama Ranoraya Tbk (IRRA.JK)

344.00 -8.00 (-2.27%)
At close: 4:05:51 PM GMT+7
Chart Range Bar
Loading chart for IRRA.JK
  • Previous Close 352.00
  • Open 354.00
  • Bid 342.00 x --
  • Ask 344.00 x --
  • Day's Range 340.00 - 356.00
  • 52 Week Range 322.00 - 615.00
  • Volume 247,100
  • Avg. Volume 1,246,069
  • Market Cap (intraday) 518.689B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 8.18
  • EPS (TTM) 42.06
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date Aug 9, 2022
  • 1y Target Est --

PT Itama Ranoraya Tbk wholesale trades in laboratory and pharmaceutical equipment, and medical devices for humans in Indonesia. It offers in vitro diagnostics products comprising rapid test, serology, glucose diagnostic, NAPZA test, and clinical laboratory; medical imaging products, including bone densitometer, C-arm, flat panel digital detector, mobile and stationary x-ray, and mammography; nefrology, blood and transfusion, orthopedic, radiotherapy, and surgical products; and hospital supplies and hospital kitchen equipment. The company also provides cold chain management, such as cold room, bloodbank, and pharmaceutical refrigerator; critical care; and pharmaceutical supplements, as well as maternal and neonatal care products. In addition, it leases office space. It sells its products under the oneject, Abbott, Terumo, DIRUI, Medtronic, mindray, ZOLL, Sansin, Vestfrost, ASCENSIA, Hemocue, CUREXO, SATInc., PT. MEGA, Planmed, Sinmed, Balmed, KSM CARE, Trisan Care, Shamrock, OTORO, GEA, Hologic, IS, Avimac, RadmediX, and SMAM brand names. The company was founded in 1988 and is based in Jakarta Timur, Indonesia. PT Itama Ranoraya Tbk operates as a subsidiary of PT Global Dinamika Kencana.

www.itama.co.id

117

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/3/2026, which may include dividends or other distributions. Benchmark is IDX COMPOSITE (^JKSE) .

YTD Return

IRRA.JK
18.87%
IDX COMPOSITE (^JKSE)
43.28%

1-Year Return

IRRA.JK
23.56%
IDX COMPOSITE (^JKSE)
40.73%

3-Year Return

IRRA.JK
27.43%
IDX COMPOSITE (^JKSE)
27.76%

5-Year Return

IRRA.JK
80.05%
IDX COMPOSITE (^JKSE)
25.15%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    6.57%

  • Return on Assets (ttm)

    2.11%

  • Return on Equity (ttm)

    11.55%

  • Revenue (ttm)

    1.04T

  • Net Income Avi to Common (ttm)

    68.25B

  • Diluted EPS (ttm)

    42.06

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    18.87B

  • Total Debt/Equity (mrq)

    188.26%

  • Levered Free Cash Flow (ttm)

    23.72B

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: